NOI - Sole Source Lab Service In Vivo.doc

DOC document 57 KB Posted

Attached to
Notice of Intent (Sole Source)- Lab Service In Vivo
Solicitation number
1230843
Issued by

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

FDA-Sole Source-1230843

Document Type:
Notice of Intent to Sole Source
Solicitation Number:
FDA - Sole Source – 1230843
Posted Date:
07/09/2020
Response Date:
07/16/2020

Intends to make a sole source award:

The Food and Drug Administration (FDA) Center for Food Safety and Nutrition (CFSAN) requires laboratory services for in vivo virulence assessment of Vibrio vulnificus isolates.

The award will be made to:

Dr. Salvador Almagro-Moreno The University of Florida 12201 Research Parkway, Suite 501 PO Box 160150

Orlando, Florida 32816-0150

In accordance with FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. The Center for Food Safety and Nutrition (CFSAN) requires laboratory services for in vivo virulence assessment of Vibrio vulnificus isolates.

The contractor shall provide adequate staff with experience in performing the intraperitoneal mouse virulence assay for V. vulnificus, in vivo virulence data on 15 isolates, and a summary of all data and expert interpretations obtained upon completion of the contract. This data is part of the ongoing research program at the FDA/CFSAN/OFS/DSST that cannot be conducted in-house.

Dr. Almagro-Moreno's laboratory is the only laboratory in the country set-up to do the particular in vivo virulence assessment that FDA requires. Dr. Almagro-Moreno and his research team have the ability to conduct the intraperitoneal mouse assay for virulence assessment of V. vulnificus and currently have an International Animal Care and Use Committee (IACUC) approved facility in which to conduct such work.

Dr. Almagro-Moreno at the University of Florida is the only contractor that can provide laboratory services for in vivo virulence assessment of Vibrio vulnificus isolates.

This notice of intent is not a request for competitive quotes. However, all responsible sources may submit a capability statement within eight (8) days after the publication of this synopsis which shall be considered by the agency. Responses received after 8 days or without the required information may not be considered. For information concerning this acquisition contact:

Tara Hobson

Contract Specialist Email: Tara.Hobson@fda.hhs.gov No phone calls please A determination by the Government not to compete because of information received is solely within the discretion of the Government. Information received will normally be considered solely for determining whether to conduct a competitive procurement.

1 | Page

File details come from the government source that posted it. Updated .